Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) EBT Margin (2019 - 2025)

Historic EBT Margin for Revolution Medicines (RVMD) over the last 6 years, with Q3 2025 value amounting to 2670.69%.

  • Revolution Medicines' EBT Margin changed N/A to 2670.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 8415.57%, marking a year-over-year increase of 847926600.0%. This contributed to the annual value of 3798.71% for FY2023, which is 30945700.0% down from last year.
  • Revolution Medicines' EBT Margin amounted to 2670.69% in Q3 2025.
  • Over the past 5 years, Revolution Medicines' EBT Margin peaked at 2670.69% during Q3 2025, and registered a low of 21724.26% during Q4 2023.
  • Its 4-year average for EBT Margin is 2736.0%, with a median of 716.15% in 2022.
  • In the last 5 years, Revolution Medicines' EBT Margin soared by 26144900bps in 2022 and then crashed by -213548500bps in 2023.
  • Quarter analysis of 4 years shows Revolution Medicines' EBT Margin stood at 556.83% in 2021, then skyrocketed by 34bps to 369.41% in 2022, then plummeted by -5781bps to 21724.26% in 2023, then skyrocketed by 112bps to 2670.69% in 2025.
  • Its EBT Margin was 2670.69% in Q3 2025, compared to 21724.26% in Q4 2023 and 2570.55% in Q2 2023.